PRECISION MEDICAL VENTURES, INC. – Trademark Portfolio
Entity Type: 03
PRECISION MEDICAL VENTURES, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include REVEALAI and REVEALDX. The owner is based in SEATTLE, WA.
500 YALE AVENUE N.
SUITE 100
SEATTLE, WA 981095680
Showing of trademarks Trademarks
Trademark Classifications
PRECISION MEDICAL VENTURES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does PRECISION MEDICAL VENTURES, INC. have?
PRECISION MEDICAL VENTURES, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.
What trademark classes does PRECISION MEDICAL VENTURES, INC. file in?
PRECISION MEDICAL VENTURES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are PRECISION MEDICAL VENTURES, INC.'s most well-known trademarks?
PRECISION MEDICAL VENTURES, INC.'s registered trademark portfolio includes well-known marks such as REVEALAI and REVEALDX. These are among 2 currently registered trademarks in the portfolio.
What is PRECISION MEDICAL VENTURES, INC.'s trademark registration success rate?
PRECISION MEDICAL VENTURES, INC. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.